| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 967 | 10.115 | 9.096 | 14.151 | 11.886 | 6.065 | 11.311 |
| Total Income - EUR | - | - | - | 967 | 17.039 | 9.096 | 19.372 | 11.886 | 11.287 | 16.504 |
| Total Expenses - EUR | - | - | - | 5.530 | 16.898 | 13.119 | 8.700 | 6.031 | 9.379 | 16.433 |
| Gross Profit/Loss - EUR | - | - | - | -4.563 | 141 | -4.022 | 10.672 | 5.855 | 1.908 | 71 |
| Net Profit/Loss - EUR | - | - | - | -4.573 | 40 | -4.133 | 10.322 | 5.499 | 1.602 | 61 |
| Employees | - | - | - | 2 | 2 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Adent Medestet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 42.894 | 36.620 | 30.586 | 24.687 | 19.526 | 14.245 | 17.820 |
| Current Assets | - | - | - | 1.154 | 681 | 164 | 9.600 | 8.591 | 7.596 | 5.125 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 100 |
| Receivables | - | - | - | 0 | 0 | 0 | 0 | 3.721 | 3.710 | 426 |
| Cash | - | - | - | 1.154 | 681 | 164 | 9.600 | 4.870 | 3.886 | 4.598 |
| Shareholders Funds | - | - | - | -4.530 | -4.403 | -15.245 | 7.279 | 12.800 | 14.363 | 10.655 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 48.577 | 41.704 | 45.995 | 27.008 | 15.316 | 7.477 | 4.610 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 8.881 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Adent Medestet Srl